When new data emerges that impacts a drug it can demand a rapid adjustment of marketing, sales and communications activity. And in certain instances, as our client discovered, it can mean a complete rebrand and relaunch. That’s no easy task when you’re also running a business and managing commercial alliances. Thankfully, our proven track record in this area can provide the necessary capability and expertise.
Clinical data for a new, large indication meant our client had to rethink their primary care drug’s commercial strategy. However, as a major multinational, this was a complex effort. They had to develop a strategy and execute this while also running the business, without increasing staff headcount, and within the context of a commercial partnership with another pharma. We were selected to support their relaunch and rebrand because of our expertise in blockbuster launches and our ability to deploy a targeted team with a bespoke combination of skills.
Our team worked closely with the Therapeutic Area and brand leadership to:
We supported the execution of a world-class launch meeting and the subsequent launch. The performance and execution exceeded projections. We delivered pre-launch training for 2,500+ sales professionals across both companies; including four programming tracks to address different specialties and customer types.
Suggested Case Studies
Register for our newsletter to receive curated insights directly to your inbox.
